In this work, our study uncovers a role of YAP in regulation of the NLRP3 inflammasome activation, and provides potential therapeutic target to treat a number of inflammatory disorders, such as atherosclerosis, gout, colitis and sepsis. This evidence concerns the gene NLRP3 and Sepsis.